secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001683168-24-007371
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals prices $3M registered direct offering of common stock and pre-funded warrants at $0.17/share
--------------------------------------------------------------------------------

- Gross proceeds ~$3M from sale of 3.7M common shares and pre-funded warrants for 13.9M shares at $0.17/share.
- A.G.P./Alliance Global Partners acting as sole placement agent; receives 6.5% fee plus up to $90k expenses.
- Closing expected Oct 24, 2024; proceeds for working capital and general corporate purposes.
- After partial exercise of pre-funded warrants, company now has 49,574,933 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007371/0001683168-24-007371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824007371/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-007371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer